文献速递乳腺外科

穿支皮瓣与其他手术技术在乳腺癌中的乳房重建对比

Breast reconstruction techniques with perforator flaps vs other surgical techniques in breast cancer.
PubMed 文献 · Surgery · 2025-08-06

该回顾性观察研究比较了346例乳腺癌手术患者中胸壁穿支皮瓣重建与其他三种术式的并发症、再切除率、复发和满意度。穿支皮瓣组并发症率11.1%,再切除率13.9%,平均随访21.4个月无局部或远处复发,86.1%患者报告美容效果良好。结论认为穿支皮瓣是保乳手术中特定患者的有效选择。

要点

  • 穿支皮瓣并发症率11.1%,与保乳术和肿瘤整形术相当,低于乳房切除重建的23.1%
  • 穿支皮瓣再切除率13.9%,低于保乳术的19.3%和肿瘤整形术的17.4%
  • 穿支皮瓣组平均随访21.4个月无局部或远处复发,86.1%报告美容效果良好

核心结论

  • 胸壁穿支皮瓣重建的并发症率和再切除率与其他手术技术相当,短期肿瘤学安全性好且患者满意度高。
  • 对于肿瘤大小或位置限制标准保乳手术的患者,穿支皮瓣是有价值的选择。

研究设计与样本

  • 回顾性对比观察研究,纳入2020至2024年间346例乳腺癌手术患者。
  • 分为四组:胸壁穿支皮瓣重建36例、无重塑保乳术161例、肿瘤整形保乳术69例、乳房切除伴或不伴即刻重建80例。
  • 并发症采用Clavien-Dindo分类,评估再切除率、局部复发和BREAST-Q满意度。

主要发现

  • 穿支皮瓣组并发症率11.1%,保乳术组11.8%,肿瘤整形术组11.6%,乳房切除重建组23.1%。
  • 穿支皮瓣组再切除率13.9%,保乳术组19.3%,肿瘤整形术组17.4%。
  • 穿支皮瓣组平均随访21.4个月,未观察到局部或远处复发。
  • 穿支皮瓣组86.1%患者报告美容效果良好。

临床怎么用

  • 对于肿瘤与乳房比例不理想或重塑能力有限的患者,可考虑胸壁穿支皮瓣作为保乳手术的容积替代技术。
  • 穿支皮瓣的并发症和再切除风险与标准保乳术及肿瘤整形术相当,短期肿瘤学结果良好。

局限性

  • 回顾性观察性研究设计,样本量有限,穿支皮瓣组仅36例。
  • 平均随访时间21.4个月,不足以评估长期肿瘤学结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Chest wall perforator flaps are increasingly used as volume replacement techniques in breast-conserving surgery for patients with unfavorable tumor-to-breast ratios or limited remodeling capacity. Their oncologic safety and complication profile compared to other standard techniques remain under evaluation. METHODS: We conducted a retrospective comparative observational study of 346 patients undergoing breast cancer surgery between 2020 and 2024. Patients were divided into 4 groups: chest wall perforator flap reconstruction (n = 36), lumpectomy without reshaping (n = 161), lumpectomy with oncoplastic mammoplasty (n = 69), and mastectomy with or without immediate reconstruction (n = 80). Surgical complications were classified using Clavien-Dindo. Re-excision rates, local recurrence, and patient satisfaction (BREAST-Q) were evaluated. RESULTS: Chest wall perforator flap patients had a complication rate of 11.1%, comparable to lumpectomy (11.8%) and oncoplastic mammoplasty (11.6%), and lower than mastectomy with reconstruction (23.1%). The re-excision rate in chest wall perforator flap was 13.9%, compared with 19.3% in lumpectomy and 17.4% in oncoplastic cases. No local or distant recurrences were observed in chest wall perforator flap patients during a mean follow-up of 21.4 months. Patient satisfaction in the chest wall perforator flap group was high, with 86.1% reporting favorable cosmetic outcomes. CONCLUSIONS: Chest wall perforator flap reconstruction offers complication and re-excision rates comparable to other surgical techniques, with excellent short-term oncologic safety and high patient satisfaction. They are a valuable option for selected patients undergoing breast-conserving surgery, particularly when tumor size or location limits the use of standard approaches.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Martín-Merino Acera MDR, Colmenarejo García E, Ferrero San Román C, et al. Breast reconstruction techniques with perforator flaps vs other surgical techniques in breast cancer. Surgery. 2025. PMID: 40774048. doi:10.1016/j.surg.2025.109586

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。